IGCS 2021 Presidential Plenary

In this video message, Dr. Coleman reveals that this year’s Presidential Plenary will focus on current clinical trials and international efforts to work cooperatively, ensuring research dedicated to women’s cancers continues to advance globally.

The Presidential Plenary will be held on Tuesday, August 31 at 2:30pm Central European Time.

During the plenary, invited guests from the GOG – (Gynecologic Oncology Group Partners) and ENGOT – (the European Network for Gynaecological Oncological Trial Group) will share the latest information and relevant clinical trials in progress. These groups operate through global partnerships and emulate so much of how the IGCS operates day in and day out… through the success of partnerships and international collaboration.


IJGC Journal Club

IJGC Journal Club, in collaboration with IGCS and ESGO
Wednesday, June 16, 2021

11:00am CDT (Chicago, USA) | 6:00pm CEST (Rome, Italy) 

June Lead Article for Discussion: 
Evaluating meaningful levels of financial toxicity in gynecologic cancers

by Katharine McKinley Esselen & Margaret I Liang

IJGC Journal Club, in collaboration with IGCS and ESGO
Wednesday, June 16, 2021

11:00am CDT (Chicago, USA) | 6:00pm CEST (Rome, Italy) 

June Lead Article for Discussion: 
Evaluating meaningful levels of financial toxicity in gynecologic cancers

by Katharine McKinley Esselen & Margaret I Liang

Watch a recording of the April Journal Club discussion.

Join Editor-in-Chief Pedro Ramirez, Social Media Editor Ane Gerda Zahl Eriksson, and the IJGC Editorial Fellows in a lively and entertaining discussion over Zoom of the lead article in IJGC's April 2021 issue.

The discussion will be recorded and made available to the public.  Participants with cameras turned on may appear in the video recording or their name may appear on the screen. By joining the zoom videoconference, participants are agreeing that they may appear in the recording. Participants can turn off their camera and change their username once they enter the zoom meeting room. To change your name on Zoom, Click the "Participants" button at the bottom of the Zoom window. Next, hover over your name in the "Participants" list and click on "Rename." Enter your new screen name and click "OK."

IGCS 2021 Registration Now Open

The 2021 IGCS Annual Global Meeting is being held in Rome at the Auditorium Parco della Musica with portions of the program being held in a digital environment so that delegates unable to travel may participate remotely.

Planning for Rome? Health & Safety Information

Safety is of course our utmost priority and the IGCS team is working very closely with a local professional conference organizer, the venue, and the Italian government as rules and regulations are released for safe ways to gather with an abundancy of caution.

  • To accommodate social distancing at the Auditorium, a maximum of 650 in-person tickets will be sold. There is no limit on virtual registration.
  • IGCS has appointed COVID Safety Officers responsible for ensuring that guidelines are followed, and proper steps are taken in the event of a positive COVID case. The names and contact information of the COVID Safety Officers will be made prominently available for all delegates to contact with any questions or for any reason before and during the meeting.
  • 48 hours in advance of the IGCS meeting, a negative COVID test result is required for delegates to be admitted to the meeting venue. IGCS will offer rapid testing at the meeting venue August 28th & 29th and will provide a list of alternate testing locations in Rome.
  • The Auditorium has provided detailed safety measures that will be shared with delegates attending in-person in advance of the meeting.
Learn More About Health & Safety Information


We continue to be most appreciative to the Società Italiana di Oncologia Ginecologica (SIOG) and the Società Italiana di Ginecologia e Ostetrica (SIGO) for their continued support and partnership in planning Rome 2021.

Read more in the welcome letter from the 2021 Scientific Program Committee Chairs. Please check back regularly for updates about the IGCS 2021 Annual Global Meeting. Join us in thinking bold!

2021 Scientific Program Committee Chairs

Ana Oaknin, MD, PhD (Spain)

Matthew Powell, MD (USA)

2021 Scientific Program Committee Roster

Co-Chair: Ana Oaknin (Spain)

Co-Chair: Matthew Powell (USA)

Angeles Alvarez Secord (USA)

Susana Banerjee (UK)

Paul Cohen (Australia)

Christina Fotopoulou (UK)

Gonzalo Giornelli (Argentina)

Salvatore Gueli Alletti (Italy)

Gustavo Guitmann (Brazil)

Saketh Guntupalli (USA)

Anuja Jhingran (USA)

Hee-Seung Kim  (Republic of Korea)

Ann Klopp (USA)

Satoru Kyo (Japan)

Mario Leitao (USA)

Domenica Lorruso (Italy)

Sven Mahner (Germany)

Vicky Makker (USA)

Xavier Matias-Guiu (Spain)

Jyoty Mayadev (USA)

Bradley Monk (USA)

Amanda Nickles Fader (USA)

Aikou Okamoto (Japan)

David O’Malley (USA)

Francesco Plotti (Italy)

Leslie Randall (USA)

Isabelle Ray-Coquard (France)

BJ Rimel (USA)

Clare Scott (Australia)

A.G.J. van der Zee (The Netherlands)

Key Dates

General Abstract Submission Deadline: May 12th
Early Registration Deadline: July 13th
Late Breaking Abstract Submission: June 8 – June 29th

Preliminary Program Details

  • 3.5 days of programming
  • Delegates may attend in person or virtually
  • Master Sessions on ovarian, cervix, uterine, and vulvar cancers are back by popular demand
  • Surgical education track
  • Oral abstract presentations
  • Continuing medical education credits for live and on-demand sessions
  • The featured poster sessions and virtual abstract poster hall will be just as robust as the 2020 meeting with the poster hall featuring audio recordings from the authors
Learn More About the Program


Optimizing Engagement with the Latest Virtual Meeting Technology and Hub & Spoke Model

Expanding on the success of the fully digital 2020 IGCS Annual Global Meeting, IGCS 2021 will utilize the latest virtual meeting technology to broadcast engaging sessions and provide delegates access to hundreds of virtual abstract posters and audio recordings.

Engagement is major priority for IGCS 2021, and we have found a unique way to disseminate our education globally without sacrificing personal interaction for those who cannot be in Rome. With the virtual platform we will be using a “hub and spoke” approach that will allow us to broadcast from Rome as the hub, to many locations where gynecologic oncology professionals may gather all over the globe – thus creating the spokes.

We are encouraging regional gatherings of delegates when conducive and identifying local key opinion leaders in each of these regions to interact with the speakers and moderators in Rome to provide a similar effect and impact as to being there in person.

Learn More About the Hub & Spoke Meeting Model


Registration Options

Delegates have the option to attend in person or participate virtually. Those who attend in person will have full access to the virtual platform. Group registration available for all options. Visit igcs2021.com/registration for more information.

Learn More About Registration Options


Uganda Fellows Complete Training

Congratulations to three fellows from the Uganda Cancer Institute for completing the IGCS Gynecologic Oncology Global Curriculum & Mentorship Program!

Dr. Pius Mulamira
Uganda Cancer Institute
Fellowship Training Completed: 2021

“I am so grateful to my mentors for your commitment to us and the program. I remain eager to learn and grow even more with your continued guidance and counsel in my career. The program has empowered me to make better decisions and judgement in the care of my patients. I am indebted to you all.”

Dr. Julius Nkalubo
Uganda Cancer Institute
Fellowship Training Completed: 2021

“Thank you all for the support. This has been one of the most impactful academic journeys I have experienced.”

Dr. Martin Origa
Uganda Cancer Institute
Fellowship Training Completed: 2021

“The IGCS Fellowship program has profoundly expanded my skill and knowledge toolkit which will definitely and positively impact my lifelong clinical practice."

The Global Curriculum was established in 2017 under the leadership of then-President, Michael Quinn. It is a comprehensive two-year education and training program designed for regions around the world that do not currently have formal training in gynecologic oncology. Click here to learn more about the program.

Congratulations to Drs. Mulamira, Nkalubo, and Origa on achieving this important milestone. Many thanks to the local and international mentors for their support and guidance.

Local Mentors - Uganda Cancer Institute

Dr. Juliet Birungi
Dr. Peter Gimei
Dr. Mariam Nabwire

Dr. Miriam Nakalembe
Dr. Carolyn Nakisige
Dr. Anthony Okoth Ndira

Dr. Jane Namugga
Dr. Nixon Niyonzima
Dr. Jackson Orem

International Mentors - Duke University School of Medicine (USA)

Dr. Paula Lee

Dr. Stephanie Ueda

Dr. Paula Lee, Gynecologic Oncologist at Duke University School of Medicine (USA) and International Mentor for the Uganda Cancer Institute congratulates the recently trained fellows:
“I am extremely proud of Pius, Julius, and Martin for their accomplishments and completion of the fellowship. They have made many sacrifices to achieve their professional goals to improve the care and outcome for women with gynecologic cancers. Their success is also a reflection of the dedication of the local mentors, especially during this past year when international mentors have not been allowed to travel due to the COVID19 pandemic. The unusual challenges have been an opportunity for growth and for local leadership to recognize the importance of paving a path for the local mentors to lead this training site in gynecologic oncology. As an external mentor, I am grateful for IGCS, the local mentors and leaders, all the faculty participating in our ECHO Tumor Board sessions, and of course to all the fellows. Congratulations Pius, Julius, and Martin!”

Volunteer to Support IGCS Mentorship & Training Programs

We are always looking for volunteer leaders of all disciplines to support our mentorship and training programs. If you are interested in becoming a mentor or contributing to our virtual tumor boards, please contact Susan Ralph at susan.ralph@igcs.org.

See all the IGCS Fellows who have completed training since 2019.

Brazilian Society of Surgical Oncology Partners with IGCS

We are pleased to announce that the Gynecologic Oncology Branch of the Brazilian Society of Surgical Oncology has joined the IGCS Strategic Alliance Partner Program.

The Brazilian Society of Surgical Oncology is a nonprofit organization that supports its members in a wide range of activities including education, research, and leadership in multidisciplinary cancer care. The BSSO helps to disseminate knowledge all over Brazil through educational events and awareness campaigns about cancer diagnosis and treatment, especially surgical treatment. The BSSO is responsible for the Certification of specialist in surgical oncology in Brazil.

Through the IGCS Strategic Partnership Alliance, over 100 new Brazilian surgical oncologists who specialize in gynecologic cancers are now a part of the IGCS Membership. They will gain access to IGCS Member benefits such as the Early Career Research & Publications Network, the online member Education Portal (including the new Pathology Corner), AAGL’s SurgeryU video library, and discounted registration for the IGCS Annual Global Meeting and contribute significantly to IGCS programs and education over time.

We want to thank the BSSO leaders who worked to make this partnership possible: Dr. Reitan Ribeiro (BSSO Scientific Director), Dr. Glauco Baiocchi, (BSSO Vice Director-International Relations), and Dr. Alexandre Ferreira Oliveira (BSSO President). Of course, we must acknowledge IGCS Council Member, Dr. Rene Pareja (Colombia) for his work in building relationships and strengthening IGCS’s reach across Latin America.

Dr. Alexandre Oliveira said, “we are pleased and honored to join the IGCS Strategic Alliance Partner Program. BSSO mission is aligned with IGCS to provide the best care of women in gynecologic cancer.”

Brazil, officially Federative Republic of Brazil, Portuguese República Federativa do Brasil, is a country in South America that occupies half the continent’s landmass. Brazil is the fifth most populous country on Earth and accounts for one-third of Latin America’s population. Most of the population is concentrated among the eastern seaboard although its capital is located far inland.

According to a study published in BMC Cancer, “There are major disparities in the availability of high-complexity oncology services and a high variability in the types of specific services available in Brazil.” In fact, the BSSO in 2020 published guidelines in the Journal of Surgical Oncology for surgical treatment of endometrial cancer in regions with limited resources, concluding that cancer patients in resource limited regions can receive adequate treatment although the first option should be referral to specialized centers with more resources.

IGCS President, Dr. Robert Coleman said, “it is very strategic for IGCS to bring the BSSO into our Strategic Alliance Program. The contributions they will make to IGCS are endless, including their surgical expertise. We are excited to share our programs and collegiality with the BSSO members.”

IGCS looks forward to our partnership with the BSSO, to serve the gynecologic cancer professionals in the region, unite them with our global community, and to find ways to achieve our common goals to fight gynecologic cancers through training, education, and public awareness.




Mary Eiken, MS

Patient Perspectives Roundtable

Spotlight on Endometrial Cancer: Breakthroughs & Concerns
Recorded on May 14, 2021
Sponsored by GSK

This Virtual Global Patient Perspectives Roundtable—focused on Endometrial Cancer —is the second in a series of four roundtables sponsored by GSK.

These topics are relevant to patient care and outcomes, options, and autonomy and are especially significant in the backdrop of COVID-19 and of global discussions of health equity. Participating in this active exchange of information across populations, specialties, and regions, attendees will enhance their understanding of these important topics and be more empowered to exercise their rights and options related to each.


Lucy Gilbert, MD, MSc, FRCOG
Professor, Department of Obstetrics and Gynecology and Department of Oncology, McGill University; Director, Division of Gynecologic Oncology, McGill University Health Center; Director, Women's Health Research Unit; Research Institute - McGill University Health Center; Creator, DOvE (Diagnosing Ovarian and Endometrial Cancers Early)
Dr. Lucy Gilbert is a Professor in the Department of Obstetrics & Gynecology and the Department of Oncology at McGill University. She heads the Tertiary/Quaternary Care Gynecologic Cancer Service of the McGill University Health Centre (MUHC) as well as its Women’s Health Research Unit. Her research focuses on novel therapeutic options for the treatment of ovarian and uterine cancers as well as technologies for their early detection. She has set up a network of satellite clinics as part of the DOvEE (Diagnosing Ovarian and Endometrial Cancers Early) project, which provide open access investigations for women with symptoms associated with gynecologic cancers. She and her team have recently developed an innovative genomic uterine pap-test called DOvEEgene to detect these cancers before they cause symptoms. The test will be offered to women 45-70 years old in the form of a clinical trial starting in May 2021.
Anne Mellon, RN
Clinical Nurse Consultant, Gynaecological Oncology, Hunter New England Centre for Gynaecological Cancer; Stream Leader Women’s Health and Gynaecology, Hunter New England WHAM Network
Anne Mellon is the Clinical Nurse Consultant in Gynaecological Oncology at the Hunter New England Centre for Gynaecological Cancer in Newcastle, NSW, Australia, a position she has held for the past 25 years. Anne is passionate about the care of women with Gynaecological Cancer and has a particular interest in endometrial cancer, vulval cancer and lymphoedema. Anne is a member of many Gynaecological Cancer advisory groups providing high level expert advice to inform the promotion of best practice gynaecological cancer care and improving gynaecological cancer outcomes. She has had a long involvement with the Cancer Nurses Society of Australia, and is a current Board Director, as well as Chair of the Gynaeoncology Specialist Practice Network.
Brian Slomovitz, MD
Gynecologic Oncologist
Professor of Gynecology and Obstetrics, Florida International University

A specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy, Dr. Brian Slomovitz is a gynecologic oncologist at Broward Health in Fort Lauderdale, Florida and a Professor of Obstetrics and Gynecology at Florida International University.

Dr. Slomovitz is part of the leadership committee at the GOG Foundation where he coordinates the uterine cancer trials. He is also the principal investigator on a number of GOG clinical trials. He authored more than 100 peer-reviewed articles and lectured extensively. In addition, Dr. Slomovitz has been recognized as a Top Doctor by Castle Connolly Medical for the past several years.

Dr. Slomovitz graduated from Rutgers University – New Jersey Medical School, and completed his residency at New York Presbyterian – Cornell Medical Center in 2002. At MD Anderson Cancer Center, he completed a fellowship in gynecologic oncology in 2006. He is board certified in both obstetrics and gynecology and gynecologic oncology.

Alexandra Taylor, MD
Member, IGCS Council
Radiation Oncologist, Royal Marsden Hospital
Chair, London Cancer Alliance Gynaecology Oncology Pathway Group; Member, National Clinical Studies Group for Gynaecological Cancer
Dr. Alexandra Taylor is a Consultant in Clinical Oncology at The Royal Marsden Hospital, London UK specialising in treatment of gynaecological cancer.  She is the IGCS Council radiation oncology representative, co-Chair of the British Gynaecological Cancer Society Guidelines Group and member of the Royal College of Radiologists Group on Artificial Intelligence in Radiotherapy.
Martha Jean Williams
Endometrial Cancer Survivor
Ambassador, Endometrial Cancer Action Network for African Americans (ECANA)

Martha Jean is energized by the beauty, joy, peace, and love that she has come to know! Her work primarily consisted of communications, nonprofit, and education. Above all, she loves serving her community. In this phase of her life, she is pursuing one of her loves, writing! Other activities she enjoys is growing herbs, cooking dishes from around the world and music! It is a privilege to serve! Being an ECANA Ambassador and a Patient Adviser is a wonderful opportunity to serve! To participate in this dialogue of health and well-being is nothing short of amazing! And the timing! My personal goal for 2020 is taking the best possible care of myself using my Lessons Learned!


Joseph Soon-Yau Ng, MD
Member, IGCS Council
Gynecologic Oncologist, National University Cancer Institute, Singapore

Dr Joseph Ng is gynecologic oncologist at the National University Cancer Institute, Singapore.  He also chairs the National University Health System’s Comprehensive Robotic Surgery program which ensures equal access to robotic surgery for all patients who need it. He is also Assistant Professor of Obstetrics and Gynecology at the National University of Singapore.

About the IGCS Patient Perspectives Roundtable Series
During the COVID-19 pandemic and in its aftermath, IGCS will continue to be a global source of education and resources, training, public awareness, and advocacy. Virtual Roundtables will

  • facilitate first-hand assessment of patient community needs and concerns
  • provide vetted information, assessments, and guidance from key opinion leaders and seasoned survivors/advocates
  • address current patient and wider community concerns through live responses to question posted online during the session
  • promote strategic conversations with health care and research communities around specific issues
  • assist all in coming to workable solutions and strategies for moving forward during the COVID-19 pandemic and in its aftermath

Each 60- to 90-minute session will cover a specific topic important to the gynecologic cancer patient communities maneuvering through the health and cancer care system during and after COVID-19 and will include IGCS key opinion leaders, patients-caregivers, and other stakeholders appropriate to the topic.

Previous Roundtables

Navigating Telehealth/Telemedicine & Embracing Shared Decision Making
Recorded November 21, 2020
Sponsored by GSK

Patient Advocacy & Support in the Backdrop of COVID-19
Recorded June 30, 2020

Gynecologic Cancer Patient Care & Clinical Trials in the Midst of COVID-19
Recorded May 23, 2020
Sponsored by GOG Foundation

Surgical Film Festival

Surgical Education Webinar
Management of Cancer in Pregnancy
Friday, May 7, 2021
10:00 - 11:00 am EDT (New York)

Program Outline

Management of placenta accreta
Michael McHale, MD

Surgical management of adnexal mass in pregnancy
Emilie Vander Haar, MD

Management of cervical cancer/preinvasive disease in pregnancy
Allan Covens, MD


Michael McHale, MD
Division Chief
Gynecologic Oncology Services
UC San Diego Health

Emilie Vander Haar, MD
Assistant Professor, Obstetrics & Gynecology
Weill Cornell Medical College
Cornell University

Allan Covens, MD
Chair, Gynecological Oncology
University of Toronto
Sunnybrook Health Sciences Centre



Vance Broach, MD
Assistant Attending, Gynecology Service
Department of Surgery
Memorial Sloan-Kettering Cancer Center

IGCS surgical film festivals are organized by Vance Broach, Surgical Education Lead of the IGCS Education Committee.

Early Career Workshop

Friday, April 30 | 8:00 pm EDT (New York)
Saturday, May 1 | 8:00 am CST (China)
Program Topics
Role of an Early Career Fellow in Clinical Trials
Alison Brand, MD 
GCIG Mandate & Vision
Keiichi Fujiwara, MD
Trial Types & Design for International Studies
Jung Min Lee, MD
Patient Reported Outcomes
Rachel Sisodia, MD
Panel Discussion/Question & Answer Segment
Rachel Sisodia, MD | Alison Brand, MD | Rhonda Farrell, MD
IGCS Early Career Workshop Jr. Faculty


Alison Brand, MD
Director Department of Gynaecological Oncology Westmead Hospital
Associate Professor, University of Sydney
Sydney, Australia
Rachel C. Sisodia, MD
Associate Professor, Harvard Medical School
Sr. Medical Director for Specialty Care & Patient Reported Outcomes, Mass General Brigham


Rhonda Farrell, MD
IGCS Early Career Network Sr. Mentor
& IGCS Council Member
Navya Nair, MD
IGCS Early Career Network Jr. Mentor
& IGCS Early Career Workshop Jr. Faculty

Early Career Workshop Jr. Faculty

Geetu Bhandoria, MD

Arthur Tsu, MD

Sadie Jones, MD

Florencia Noll, MD

While the workshop is open to all, the program is geared towards young clinicians and researchers who are currently in training and those who have completed training within the last five years and are dedicated to the study of gynecologic cancers.

This workshop is being coordinated in collaboration with the Gynecologic Cancer Intergroup (GCIG).

The session recording and slides from the first IGCS Early Career Workshop (held January, 2021) are available for IGCS Members in the Education Portal.

Zoom Video Webinar

IGCS uses Zoom Video Webinar for virtual events. Zoom Webinar technology has a maximum capacity of 500 attendees. While we believe that we will be able to accommodate all attendees, these free sessions have garnered a lot of interest and there is a chance that capacity will be reached. Also, please be aware that poor internet connectivity and other issues may affect the quality of your experience. Click here to view tips to improve your Zoom Webinar connectivity.

If you are unable to enter the Zoom Webinar or experience technical difficulties, please know that a recording of the entire session will be made available on the IGCS website in a timely manner after the event.

Nominations for Distinguished Advocacy Award

The Annual IGCS Distinguished Advocacy Award recognizes advocates and/or advocacy organizations that provide active, dedicated service to patients-survivors, families, caregivers, and communities—at a local, regional, or international level. The Award, reserved for those most persistently engaged in the fight against gynecologic and other cancers,

  • recognizes those currently engaged in activities and projects that tangibly provide benefit to patient-survivor communities
  • highlights best practices and outstanding individuals and organizations in various settings throughout the world
  • inspires others to engage so generously

Annually, IGCS honors up to three individuals and organizations from different regions of the world, and special consideration is given to those who collaborate beyond their community or country of residence. Award recipients will

  • receive complimentary registration to virtually attend the 2021 IGCS Annual Global Meeting (August 30 - September 2)
  • be recognized at the Global Meeting during the Opening Ceremony and during the Survivor-Caregiver Symposium (awardees will be asked to record a 2- minute acceptance speech)
  • receive a plaque in recognition of the Award
  • be highlighted on the Advocacy pages of the IGCS website

Nominations are currently closed.

IGCS is no longer accepting nominations for its 2021 Distinguished Advocacy Award. The deadline for receipt of nominations was May 7, 2021. Award recipients will be determined by a Selection Committee with IGCS Council consultation. In selecting award recipients, we will consider global distribution of the award and regional ableness; however, these will not be the primary considerations. We accept self-nominations.

Award recipients must be patients-survivors, family members, caregivers, or other individuals who make outstanding contribution(s) to the patient-survivor community and be engaged in one or more of the following areas:

  • advocating for enhanced cancer awareness and prevention
  • providing or advocating for the delivery of the highest-quality cancer care
  • supporting achievement of the highest quality of life possible (to include support or palliative care)
  • implementing program(s) that support and/or advance health equity
  • collaborating with other advocates and/or advocacy organizations to benefit patients-survivors across geographic boundaries and demographics

Nominees do not have to belong to an established organization but must be active in their own community and/or beyond. In each calendar year, only one person or organization from a region can receive the Award.

If you have questions, please email the IGCS Director of Global Outreach and Engagement, Mary (Dicey) Jackson Scroggins at dicey.scroggins@igcs.org.

Previous Recipients

Gynecologic Oncology of Canada Partners with IGCS

We are pleased to announce that The Society of Gynecologic Oncology of Canada (GOC) has joined the IGCS Strategic Alliance Partnership. IGCS and GOC are aligned in many ways including the GOC’s purpose, to improve the care of women with or at risk of gynecologic cancer by raising standards of practice, encouraging ongoing research, promoting innovation in prevention, care and discovery, and advancing awareness.

Gynecologic oncology was recognized in 1989 by the Royal College of Physicians and Surgeons of Canada, due in large part to GOC’s ongoing commitment to the development of practice guidelines, training standards and research goals in women’s reproductive cancer care. Subspecialty certification examinations by the Royal College of Physicians and Surgeons of Canada began in 2010.

Today over 216 of all gynecologic oncologists practicing in Canada are members of GOC. Its membership reflects the multi-disciplinary approach to cancer care and includes medical oncologists, radiation oncologists, pathologists, fellows-in-training, residents, nurses specializing in gynecologic cancer care, scientists and pharmacists who devote a significant amount of their practice to the treatment and research of gynecological cancer.

GOC members will now benefit from dual membership and gain access to IGCS Member benefits such as the Early Career Research & Publications Network, the online member Education Portal (including the new Pathology Corner), AAGL’s SurgeryU video library, discounted registration for the IGCS Annual Global Meeting, and access to our online member community Social Link to name a few.

Canada, with a population of 38 million, is the largest country in the Western hemisphere and the second-largest country in the world after Russia. According to the International Agency for Research on Cancer, breast cancer is the most prevalent cancer affecting women in Canada with cervical cancer being the number-four cause of cancer-related deaths after breast, lung and colorectum cancer.

Dr. Helen Mackay, GOC’s President, had this to say: “At GOC, we are ready to push the envelope by developing new ways of thinking, involving the next generation of healthcare professionals with an interest in gyn cancers and partnering with like-minded organizations such as IGCS. Most importantly, we aim to also include women in the discussion to find novel solutions and work towards the eradication of gynecologic cancers. We are excited for this next chapter in our history.”

IGCS President, Dr. Robert Coleman echoes the sentiment of the GOC and feels “having GOC has a strategic alliance partner allows IGCS to further our work under our new health equity statement. We welcome our Canadian colleagues and look forward to our great partnership.”

We look forward to our partnership with GOC, to serve the gynecologic cancer professionals in the region, unite them with our global community, and to find ways to achieve our common goals to fight gynecologic cancers through training, education, and public awareness.